ZAG调控特应性皮炎的皮肤屏障与免疫
该研究在AD患者血清、T细胞和皮肤中均发现ZAG(一种调控脂质动员的脂肪因子)水平降低,且ZAG主要与FLG和LOR共同分布于角质层。敲低ZAG导致FLG减少、TSLP增加;在AD小鼠中局部外用ZAG可恢复皮肤ZAG表达,改善AD样症状、经皮水分丢失和神经酰胺水平,并诱导免疫调节效应。
要点
- AD患者血清、T细胞及皮肤中ZAG水平较健康对照持续降低。
- 敲低ZAG致FLG下降、TSLP上升,提示其参与屏障与免疫调控。
- AD小鼠局部外用ZAG可改善症状、TEWL及神经酰胺,并调节免疫。
核心结论
- ZAG缺乏与AD的皮肤屏障功能障碍及免疫异常密切相关。
- 恢复ZAG可能是治疗AD的有前景的治疗选择。
研究设计与样本
- 研究检测了人AD患者与健康对照的血清、T细胞和皮肤中ZAG水平。
- 采用短发夹RNA敲低ZAG,并在AD小鼠中进行局部ZAG治疗实验。
主要发现
- ZAG在AD患者血清、T细胞和皮肤中较健康对照持续降低。
- ZAG主要与FLG和LOR共同分布于角质层。
- 敲低ZAG导致FLG减少、TSLP增加。
- AD小鼠局部外用ZAG可恢复皮肤ZAG表达,改善AD样症状、经皮水分丢失和神经酰胺水平。
- 局部ZAG治疗降低皮肤和淋巴器官中IL-4、IL-17、IFN-γ并增加Foxp3,同时恢复ADAM17降低的水平。
临床怎么用
- ZAG可作为AD的生物标志物进行进一步评估。
- 恢复ZAG可能成为AD的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adipokines modulate immune responses and lipid metabolism in allergic disease; however, little is known about their role in the skin barrier and atopic dermatitis (AD). We identified ZAG, an adipokine that regulates lipid mobilization, as a biomarker for AD. ZAG levels were consistently decreased in sera, T cells, and skin in human AD patients compared with healthy controls. ZAG was primarily detected in the stratum corneum along with FLG and LOR. Knockdown of ZAG with short hairpin RNA resulted in decreased FLG and increased TSLP. Topical ZAG treatment in AD mice recovered ZAG expression in the skin and improved AD-like symptoms, transepidermal water loss, and ceramide levels. Furthermore, topical ZAG treatment induced immunoregulatory effects, including reduction of IL-4, IL-17, and IFN-γ and increased Foxp3 in the skin and lymphoid organs. Interestingly, ZAG treatment also recovered decreased levels of ADAM17, an important player in skin barrier function and immune response in AD. Thus, ZAG deficiency is closely related to skin barrier function and the immune abnormalities of AD, and we suggest that restoration of ZAG may be a promising therapeutic option for the treatment of AD.
引用
- Noh JY, Shin JU, Kim JH, et al. ZAG Regulates the Skin Barrier and Immunity in Atopic Dermatitis. J Invest Dermatol. 2019. PMID: 30738053. doi:10.1016/j.jid.2019.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。